Loading Results
We have updated our Online Services Terms of Use and Privacy Policy. See our Cookies Notice for information concerning our use of cookies and similar technologies. By using this website or clicking “I ACCEPT”, you consent to our Online Services Terms of Use.
Find University Hospitals Doctors
Kevin Kilgallon, MD

Kevin Kilgallon, MD

  • Languages Spoken: English

Biography: Kevin Kilgallon, MD


  • Cardiac Critical Care
  • Extracorporeal Membrane Oxygenation (ECMO)
  • Mechanical Circulatory Support


  • Assistant Professor, CWRU School of Medicine

Certifications & Memberships

  • Pediatric Critical Care Medicine - American Board of Pediatrics
  • Pediatrics - American Board of Pediatrics


Fellowship | ECMO (Extracorporeal Membrane Oxygenation)
ECMO (Extracorporeal Membrane Oxygenation) - Children's Hospital Colorado - Anschutz Medical Campus (2021 - 2022)

Fellowship | Pediatric Critical Care Medicine
Pediatric Critical Care Medicine - Children's Hospital Colorado - Anschutz Medical Campus (2018 - 2021)

Residency | Pediatrics
Pediatrics - Nationwide Children's Hospital (2015 - 2018)

Medical Education | Medicine
Medicine - University Of Illinois School Of Medicine, Rockford (2015)

Washington University In St Louis (2010)


Kevin Kilgallon, MD is a pediatric cardiac intensivist. His academic and clinical interests include extracorporeal life support, cardiac critical care, and medical education. His goal is to provide excellent clinical care of his patients and their families in the cardiac ICU, and to push the boundaries of knowledge of extracorporeal support knowledge through both teaching and research.

Industry Relationships

University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.

UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.

View UH’s policy (PDF) on practitioner-industry relationships.

As of December 31, 2016, Kevin Kilgallon did not disclose any Outside Relationships with Industry.